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Abstract

There is evidence that the environmental toxin β-N-methylamino-L-alanine (L-BMAA) may be involved
in neurodegenerative diseases. However, a number of controversies exist regarding L-BMAA, one of

which is the possibility that when assaying for L-BMAA, its isomers are being detected instead. There
are at least four isomers of BMAA that are known to occur: L-BMAA, β-N-methylamino-D-alanine (DBMAA), 2,4-diaminobutyric acid (DAB), and N-(2-aminoethyl)glycine (AEG). The fact that isomers of
BMAA exist in nature also leads to the possibility that they are involved in toxicity. We set out to
determine both the potency and the mechanism of toxicity of L-BMAA, D-BMAA, DAB, asnd AEG using
primary cortical cultures. The results were surprising with the following order of potency of toxicity:
AEG > DAB > D-BMAA > L-BMAA. These results suggest that AEG may be an overlooked neurotoxin. We
found that AEG induced toxicity through mGluR5 receptors and induction of oxidative stress. While the
potential role of L-BMAA in neurodegenerative diseases has been emphasized, other isomers of LBMAA, particularly AEG, are actually more potent toxins, and could therefore potentially contribute to
neurodegenerative diseases.
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1. Introduction

L-BMAA is a non-protein amino acid neurotoxin produced by cyanobacteria that was first implicated in
the neurodegenerative disease amyotrophic lateral sclerosis/Parkinson's Dementia Complex (ALS/PDC)
on Guam (Cox et al., 2003). Since these initial reports, a number of studies have suggested that LBMAA may be involved in neurodegenerative diseases, not only on Guam, but also throughout the
world. First, cyanobacteria widely distributed around the world have been shown to produce L-BMAA
(Cox et al., 2005; Esterhuizen and Downing, 2008; Metcalf et al., 2008). Second, L-BMAA is
biomagnified in systems not only on Guam (Cox et al., 2003), but also in the Baltic Sea (Jonasson et al.,
2010), the Gulf of Mexico (Brand et al., 2010), France (Réveillon et al., 2014), and China (Li et al., 2019).
Third, L-BMAA can become protein-associated which allows it to build up in tissue and provides a
mechanism for slow release (Murch et al., 2004). Fourth, L-BMAA is found not only in brain samples of
ALS/PDC patients in Guam, but also in the brains of Alzheimer's disease and ALS patients from North
America (Pablo et al., 2009). Fifth, clusters of ALS patients have been found around cyanobacteria
producing lakes (Caller et al., 2009), with aerosolization of L-BMAA being a possible route of exposure
(Stommel et al., 2013). These results suggest that L-BMAA may be of concern not only for people on
select pacific islands, but may represent a wider health concern.
However, a number of controversies exist regarding L-BMAA, one of which is the possibility that when
assaying for L-BMAA, isomers of L-BMAA are detected instead. This is of particular importance since
there is debate concerning the presence of L-BMAA under various conditions. For example, L-BMAA is
not always detected in the brains of neurodegenerative disease patients (Montine et al., 2005) or even
in cyanobacteria (Rosen and Hellenas, 2008). One explanation proposed for the discrepancies in the
results is that the detection of isomers of L-BMAA may confound some studies (Jiang et al., 2012). The
fact that isomers of L-BMAA exist in nature, also leads to another possibility, that is, it is possible that
these isomers are also involved in toxicity. BMAA has at least four isomers that are known to occur: LBMAA and its mirror image D-BMAA, 2,4-diaminobutyric acid (DAB), and N-(2-aminoethyl)glycine
(AEG). There are numerous studies showing the presence of L-BMAA, DAB, and AEG in biological
samples (reviewed by: Lance et al., 2018) and they each appear to be produced by cyanobacteria,

diatoms, and dinoflagellates (Chatziefthimiou et al., 2018). There is only one study regarding the
presence of D-BMAA in biological systems. Metcalf et al., (2017) did not find the presence of D-BMAA
in cyanobacteria. However, they did find that when vervets, or mice, were treated with L-BMAA, it was
only D-BMAA that was detected in the animal's central nervous system.
Since isomers of L-BMAA exist in nature, it is possible that they are important not only for complicating
the analysis of L-BMAA levels, but also as potential neurotoxins themselves. We set out to determine
the toxicity of each of the BMAA isomers in primary cortical cultures.

2. Material and methods
2.1. Cortical cell cultures

Mixed cortical cell cultures containing neuronal and glial cells were prepared from fetal (15–16 day
gestation) mice as previously described (Lobner, 2000). Briefly, dissociated cortical cells were plated on
24 well plates coated with poly-D-lysine and laminin in Eagles' Minimal Essential Medium
supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM glutamine and
glucose (total 21 mM). Astrocyte-enriched glial cultures were prepared as described for mixed cultures
except they were from cortical tissue taken from post-natal day 1–3 mice. Cultures were maintained in
humidified 5% CO2 incubators at 37 °C. Mice were handled in accordance with a protocol approved by
our institutional animal care and use committee and in compliance with the National Research
Council's Guide for the Care and Use of Laboratory Animals.

2.2. Induction of neuronal death

Experiments were performed on mixed cortical cultures 13–15 days in vitro (DIV). Toxicity was induced
by exposure to the toxic agents for 24 h in media as described for plating except without serum.
Experiments were performed without serum to prevent interference from the many, and not
completely characterized, compounds found in serum. However, this does add the potential confound
of the media being different for the experiments from that in which the cells were grown. In
experiments involving receptor antagonists or free radical scavenger compounds they were added at
the same time as the toxins.

2.3. LDH release

Cell death was assessed in mixed neuronal and glial cultures by the measurement of lactate
dehydrogenase (LDH), released from damaged or destroyed cells, in the extracellular fluid 24 h after
the beginning of the insult. Blank LDH levels were subtracted from insult LDH values, and results
normalized to 100% neuronal death caused by exposure to 500 μM NMDA. Control experiments have
shown previously that the efflux of LDH occurring from either necrotic or apoptotic cells is proportional
to the number of cells damaged or destroyed (Lobner, 2000).

2.4. 14C-cystine uptake

For 14C-cystine uptake, astrocyte-enriched glial cultures were washed into HEPES buffered saline
solution and immediately exposed to 14C-cystine (0.025 μCi/mL) for 20 min with or without the toxins
present. Following 14C-cystine exposure, all cultures were washed with HEPES buffered saline solution
and dissolved in 250 μL warm sodium dodecyl sulfate (0.5%). A 200 μL aliquot was removed and added

to scintillation fluid for counting. Values were normalized to 14C-cystine uptake in untreated controls
on the same experimental plate.

2.5. Statistical analysis

Differences between test groups were examined for statistical significance by means of one-way
ANOVA followed by the Bonferroni correction post-hoc test, with p < 0.05 being considered significant.

3. Results

It has been known since the 1980's that L-BMAA is neurotoxic in cortical cell culture, but that the
induction of neuronal death by L-BMAA required high concentrations (Weiss et al., 1989). We repeated
the studies using L-BMAA in mixed neuronal and glial cortical cultures and found similar results, with
no significant toxicity occurring until an L-BMAA concentration of about 1 mM (Fig. 1A). Also, as we
have found previously, D-BMAA (Metcalf et al., 2017), is a slightly more potent neurotoxin than LBMAA (Fig. 1B). We now tested the toxicity of DAB and AEG under the same conditions in cortical
cultures. We found that DAB was also a more potent neurotoxin than L-BMAA (Fig. 1C), and that AEG
was the most potent neurotoxin (Fig. 1D). The EC50 for the induction of neuronal death for each
compound was as follows: L-BMAA 1463 μM; D-BMAA 445 μM; DAB 365 μM; AEG 18 μM.

Fig. 1. Toxicity of varying concentrations of L-BMAA (A), D-BMAA (B), DAB (C), and AEG (D) following 24 h
exposure of mixed cortical cultures to the toxins. Bars show % neuronal death (mean ± s.e.m, n = 8–16)
quantified by measuring LDH release. * indicates significantly different from control.

We have previously determined the mechanism of L and D-BMAA toxicity in cortical cultures, with LBMAA toxicity involving induction of free radicals as well as activation of NMDA and mGluR5 type
glutamate receptors (Lobner et al., 2007), while D-BMAA toxicity was mediated by activation of AMPA
type glutamate receptors (Metcalf et al., 2017). We now examined the mechanism of DAB and AEG
toxicity. DAB toxicity was mediated by activation of NMDA receptors as toxicity was attenuated by the
NMDA receptor antagonist memantine (Fig. 2A), while AEG toxicity was mediated by the induction of
free radicals and the activation of mGluR5 receptors as its death was partially attenuated by the free
radical scavenger Trolox and the mGluR5 receptor antagonist 6-methyl-2-[phenylethynyl]-pyridine
(MPEP) (Fig. 2B). The AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo
[f]quinoxaline (NBQX) had no effect on the toxicity of either compound (Fig. 2).

Fig. 2. Toxicity of DAB is mediated by NMDA receptors (A), and AEG by mGluR5 receptors and oxidative stress
(B). Cell death assayed 24 h after exposure of mixed cortical cultures to the toxins with or without protective
agents present. Bars show % neuronal death (mean ± s.e.m, n = 16) quantified by measuring LDH release. *
indicates significantly different from control. MEM: 10 μM memantine, NBQX: 10 μM NBQX, MPEP: 50 μM
MPEP, Trolox: 100 μM Trolox.

One possibility for induction of oxidative stress by L-BMAA and AEG is that they inhibit cystine uptake.
Cystine is a precursor for production of the endogenous free radical scavenger, glutathione. In previous
studies we have shown that about 80% of cystine uptake in astrocyte-enriched glial cultures is through
system xc- (Liu et al., 2012). Testing the effects of BMAA isomers on 14C-cystine uptake in astrocyte
enriched glia cultures we found that L-BMAA at concentrations starting at 300 μM inhibited cystine
uptake (3 A), while D-BMAA actually caused an increase in cystine uptake (Fig. 3B). DAB significantly
decreased cystine uptake, but only at the high concentration of 1 mM (Fig. 3C). AEG decreased cystine
uptake beginning already at a concentration of 10 μM, although the effect disappeared at the 1 mM
concentration (Fig. 3D).

Fig. 3. 14C-cystine uptake in astrocyte-enriched glial cultures in the presence of varying concentrations of LBMAA (A), D-BMAA (B), DAB (C), and AEG (D). 14C-cystine uptake was measured for 20 min with or without the
toxins present. Results are expressed as mean ± s.e.m (n = 12) after normalizing to untreated control uptake. *
indicates significantly different from control.

4. Discussion

The most surprising results obtained were that L-BMAA was a less potent toxin than its isomers and
that AEG was by far the most potent neurotoxin. The importance of these findings is dependent on
whether humans are likely to be exposed to these isomers. There are numerous studies involving the
measurement of L-BMAA, and its isomers DAB and AEG, in the environment (reviewed by: Lance et al.,
2018). Each of these isomers have been shown to accumulate in organisms that are consumed by
humans, such as, mussels (Reveillon et al., 2014, 2015), oysters (Réveillon et al., 2014), ansd shark fins
(Mondo et al., 2014). It is a harder to determine which of the compounds occur at the highest level in
nature, as not all isomers are measured in each study, and results vary widely, likely dependent of the
assay method. However, it is of interest that in shark fins, AEG levels were about 10 times higher than
L-BMAA or DAB (Mondo et al., 2014). There is only one study regarding the presence of DBMAA. Metcalf et al., (2017) did not find D-BMAA in cyanobacteria. However, they did find that when
vervets or mice were treated with L-BMAA, there was only D-BMAA found in the animal's central
nervous system, suggesting a conversion from L-BMAA to D-BMAA. Therefore, exposure of humans to
each of these compounds is possible.
The current study was performed in cell culture and therefore does not directly address the question
of toxicity due to in vivo exposure. L-BMAA toxicity has been studied in animal models, with variable
results. Oral intake of L-BMAA by rodents has not shown to have any effects (Perry et al., 1989; CruzAguado et al., 2006). Although oral consumption of L-BMAA induces features of neurodegenerative
diseases in vervets (Banack and Cox, 2018) and there are numerous studies showing neurotoxicity
caused by injections of L-BMAA in rodents (Caller et al., 2018). There is some evidence that DAB can
have neurological effects in animals. Intraperitoneal injection of DAB in rats can cause convulsions
(Chen et al., 1972) and enhance catalepsy induced by a GABA uptake inhibitor (Williams and Davies,
1979). There are no studies of D-BMAA or AEG toxicity in an animal model.

Correlating the concentrations of L-BMAA isomers tested in these studies to the concentrations found
in the most relevant condition, that is, in the interstitial fluid surrounding neurons and astrocytes in the
central nervous system is very difficult. Certain relevant facts are known about L-BMAA. It has been
shown that approximately 80% of oral L-BMAA is absorbed (Duncan et al., 1991) and it is transported
into the brain where it accumulates in a number of regions, including the hippocampus (Karlsson et al.,
2009). The amount of L-BMAA found in the brains of Alzheimer's disease patients from North America
was about one-fifth that found in ALS/PDC patients from Guam (111 ± 14 μg/g vs. 627 ± 141 μg/g).
However, much of this L-BMAA is in a form described as protein associated and how this correlates
with free L-BMAA in the interstitial fluid in the brain is unknown. Much less is known about the
absorption, transport into the brain, and brain accumulation of the other BMAA isomers. These
questions will need to be answered to the determine the importance of the current studies.
We have shown previously that toxicity of L-BMAA in cortical culture is mediated by action at NMDA
and mGluR5 receptors, as well has induction of free radicals (Lobner et al., 2007), while D-BMAA
induces neuronal death specifically through action at AMPA receptors (Metcalf et al., 2017). The
current study indicates that DAB causes neurotoxicity by acting at NMDA receptors, while AEG acts
both at mGLuR5 receptors and induces oxidative stress. Therefore, the common feature of L-BMAA
and AEG toxicity is the induction of oxidative stress. The results are generally consistent with inhibition
of cystine uptake through system xc-playing a role in the oxidative stress mediated toxicity of L-BMAA
and AEG. System xc-is a sodium-independent amino acid transporter found primarily on astrocytes,
which takes up one molecule of cystine into the cell in exchange for one molecule of glutamate (Bannai
and Kitamura, 1980; Bannai, 1986). The cystine that is imported is quickly reduced to cysteine and used
to synthesize glutathione (GSH) (Bannai and Kitamura, 1980). GSH is the main endogenous antioxidant
in the brain and protects against oxidative stress; it can be released by astrocytes and used to protect
neurons (Shih et al., 2006). Both of the compounds inhibit cystine uptake, but AEG is much more
potent at both this action and at inducing neuronal death. In fact, the concentrations of L-BMAA and
AEG to induce toxicity and their ability to inhibit cystine uptake are generally consistent. The
compounds undoubtedly have actions other than effects on system xc-. For example, L-BMAA can also
act downstream in the glutathione pathway by inhibiting glutathione peroxidase and glutathione
reductase (Esterhuizen-Londt et al., 2011). It is unknown whether AEG also has this action and it has in
general been studied much less than L-BMAA. Also, the fact that AEG no longer inhibits cystine uptake
at a concentration of 1 mM, yet is highly toxic at that concentration, indicates that it can induce
toxicity through other mechanisms at high concentrations.
The reason for the difference in the effects of L-BMAA and D-BMAA, particularly on cystine uptake,
where L-BMAA causes a decrease, while D-BMAA causes an increase, is not known. One possibility for
the difference is that the function of L-BMAA is known to be altered by its interaction with bicarbonate
to form a carbamate adduct. All of the current experiments were performed in the presence of
bicarbonate. It is not known whether D-BMAA has a similar interaction with bicarbonate, but if it
doesn't have this interaction, this could potentially account for its very different actions than L-BMAA.
A previous cell culture study failed to show the high potency of AEG toxicity that we observed (Main
and Rodgers, 2018). However, that study was performed in a neuroblastoma cell line (SH-SY5Y cells)
which likely has different sensitivity to various types of injury. For example, they observed that L-BMAA

toxicity was mediated by endoplasmic reticulum stress and disturbances in protein synthesis, folding,
and turnover. The type of toxicity observed in the current study involved activation of glutamate
receptors and effects on system xc-likely play a greater role in primary neurons than in cell lines. The
fact that oxidative stress and glutamate receptor mediated toxicity occur during neurodegenerative
diseases (Fan et al., 2017) suggests that the toxicity observed by BMAA isomers such as AEG in these
studies may be relevant to disease conditions.

5. Conclusion

All four BMAA isomers are toxic, with L-BMAA surprisingly being the least potent toxin and AEG being
the most potent. To date, emphasis has been placed on studying the potential role of L-BMAA in
neurodegenerative diseases, however the potential exists that its isomers could contribute to these
diseases. The production, distribution, and role in disease of BMAA isomers should be further studied.
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